Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Tablets × Clear all

Sponsor

Conditions

Neoplasms 5 Breast Neoplasms 3 Neoplasm Metastasis 2 Leukemia, B-Cell 2 Urinary Bladder Neoplasms 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Nivolumab 11 Ipilimumab 6 linrodostat 4 relatlimab 3 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 mirdametinib 1 gedatolisib 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tetanus Toxoid 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Irinotecan 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Cyclophosphamide 1 Crizotinib 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡